#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Iron overload Congenital leptin deficiency Neuroendocrine tumour Congenital ectodermal dysplasia Stiff person syndrome Hyperphagia Peritoneal mesothelioma malignant Transient ischaemic attack Paraneoplastic neurological syndrome Rectal cancer Aicardi-Goutieres syndrome Immunodeficiency congenital Still's disease Angelman's syndrome Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Trials in Disease Optic glioma Ewing’s sarcoma – Basic Information Usher’s syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Hereditary ataxia – Trials in Disease Hereditary hypophosphataemic rickets – Treatment Krabbe’s disease – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Mucous membrane pemphigoid – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Potassium Oxybate Dexamethasone Acetate Delandistrogene Moxeparvovec Bms-986442 Cisplatin LY3841136 SODIUM Aclidinium Bromide Festuca Elatior Pollen Extract Ieramilimab Sodium Cromoglicate Magnesium Sulfate Heptahydrate Tebipenem Pivoxil Hydrobromide PIPOTIAZINE Ianalumab Verapamil Hydrochloride Imipenem R3R01 Pf-06835375 Gskvx000000017033 Eribulin Mesylate More therapies…

    Learn about Your Condition

    Cytomegalovirus infection Circulatory collapse Genital herpes Endometrial cancer stage IV Lymphangioma Epstein-Barr virus infection Acute lymphocytic leukaemia Retinopathy proliferative Urethral valves Arthroscopy Multifocal motor neuropathy Vertigo Emphysema Pyoderma gangrenosum Depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Allogenic stem cell transplantation

  • Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

    Recruiting

    2 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Study on Semaglutide for Reducing Mucositis in Patients Undergoing High-Dose Chemotherapy with Stem Cell Transplantation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Autologous haematopoietic stem cell transplant
    • Allogenic stem cell transplantation
    • Acute leukaemia
    Investigated Drugs:
    • FOSFOMYCIN CALCIUM
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    Spain

  • Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Allogeneic Umbilical Cord-Derived Cd34- Cells, Non-Expanded
    • Dorocubicel
    The Netherlands

  • Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

    Not recruiting

    3 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Graft versus host disease
    Investigated Drugs:
    • Itolizumab
    Belgium France Germany Italy Portugal Spain
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!